Basilea Pharmaceutica AG
Basilea Pharmaceutica AG (BPMUF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BPMUF · as of Jun 9, 2026
Key Statistics
Explore Basilea Pharmaceutica AG Data
bpmuf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
bpmuf competitorsBPMUF
BJTRF
FOGCF
GSGTF
INRLF
MDCLFStock Performance
Full HistoryAbout Basilea Pharmaceutica AG
Basilea Pharmaceutica AG is a biopharmaceutical company already generating revenue from its products, which are designed to fulfill medical needs in the challenging areas of cancer (oncology) and infe…
what is basilea pharmaceutica ag · bpmuf stock overview · basilea pharmaceutica ag company profile · who is basilea pharmaceutica ag ceo · bpmuf OTC · basilea pharmaceutica ag headquarters · basilea pharmaceutica ag business segments
About Stock Overview & Key Data
Basilea Pharmaceutica AG (BPMUF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jun 9, 2015. As of the latest trading session, BPMUF stock price is $65.10, with a market capitalization of $805.6M. The stock has returned +12.82% over the past 12 months and +2.92% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Basilea Pharmaceutica AG stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Basilea Pharmaceutica AG reported revenue of $232.5M and net income of $40.2M. For detailed data — including Basilea Pharmaceutica AG revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Basilea Pharmaceutica AG (BPMUF) stock price is $65.10. The stock is traded on OTC under the ticker symbol BPMUF. The 52-week range is $47.50 – $74.00.